GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast-track ...
4,789,897 reviews on ConsumerAffairs are verified. We require contact information to ensure our reviewers are real. We use intelligent software that helps us maintain the integrity of reviews. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results